Lung cancer: Could neuronal autoantibodies cause ‘brain fog’?
Cognitive deficits experienced by patients might not be due to their treatment, neurologists suggest
Neuronal autoantibodies might play a role in the cognitive impairment that affects two-thirds of patients with lung cancer, German researchers say.
Neurologists, immunologists and lung cancer specialists teamed up for a study in which serum from 167 patients with lung cancer (mean age 66 years, 63% men, 55% stage IV disease) was examined for the presence of neuronal autoantibodies.
